Goodwin represented neuroscience company Cerevance in a $5 million extension of its Series A financing. The additional funding was provided by the Dementia Discovery Fund, an…
Cerevance’s $5 Million Extension to Series A Financing
Goodwin represented neuroscience company Cerevance in a $5 million extension of its Series A financing. The additional funding was provided by the Dementia Discovery Fund, an…